Form 4: Pfizer Director Joseph Echevarria Acquires Phantom Stock

Pfizer Inc. Director Joseph Echevarria acquired 1,904.076 phantom stock units on June 26, 2026, as part of a deferred compensation plan.

Summary

• Joseph Echevarria, a Director at Pfizer Inc., acquired 1,904.076 phantom stock units on June 26, 2026.
• These units represent deferred director's compensation, including dividend equivalents.
• The phantom stock units are settled in cash or common stock upon the reporting person's retirement from the Board of Directors.
• The acquisition value is noted as $24.29 per unit, totaling 165,631.508.
• Echevarria's beneficial ownership of these securities is direct.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard component of director compensation rather than a new strategic investment or a significant personal stake increase.

Positives

• Director acquisition of company stock, even in the form of phantom units, can signal confidence in the company's future prospects.
• The deferred compensation structure aligns long-term incentives for directors with shareholder value.

Negatives

• The transaction involves phantom stock units, which are not direct ownership of common stock until settlement.
• The filing does not provide details on the specific market conditions or rationale behind this specific acquisition timing.

Risks

• The value of the phantom stock units is subject to fluctuations in Pfizer's common stock price.
• Settlement of these units is contingent upon the reporting person's retirement from the Board of Directors.

Future Outlook

The phantom stock units will be settled in cash or common stock at the director's election following retirement from the Board of Directors, indicating a long-term commitment and potential future shareholding.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of phantom stock units by a director, are common within the pharmaceutical industry as a method for long-term incentive alignment and director compensation.

Related Party Transactions

• The acquisition of phantom stock units by Director Joseph Echevarria is a form of compensation and thus a related party transaction.

Stakeholder Impact

• Shareholders: The acquisition by a director may be perceived positively, suggesting confidence, but it does not immediately increase the public float of shares.
• Employees: No direct impact.
• Creditors: No direct impact.
• Suppliers: No direct impact.

Next Steps

• Settlement of phantom stock units in cash or common stock upon Joseph Echevarria's retirement from the Board of Directors.

Key Dates

Keywords

Pfizer, PFE, Form 4, Insider Trading, Director Compensation, Phantom Stock, Deferred Compensation, Securities Ownership